DEVELOPING NEXT GENERATION MEDICINES
We develop therapies designed to evolve alongside disease, helping outpace resistance in cancer, bacteria, and viral disease.
Why Evolvable Medicine
Many diseases evolve faster than the medicines designed to treat them.
Viruses mutate, cancers adapt, and drug resistance emerges again and again.
The Institute for Evolvable Medicines develops therapies designed to adapt alongside the diseases they target—staying one step ahead of resistance.
Understanding the Science
A BRIEF INTRODUCTION TO EVOLVABLE MEDICINES
Leadership Team
Leor S. Weinberger, PhD
Founder & President
Galyn Susman
Co-Founder & Chief Operating Officer